Catalyst Biosciences (NASDAQ:CBIO) Stock Rockets As Company Is Selling Its Protease Medicines Portfolio

May 24, 2022

If there is one stock that is expected to be on the radars of most investors today, then it is the Catalyst Biosciences (NASDAQ:CBIO) stock, which had managed to clock gains of as much as 235% on Monday following a key development. Trading Data On Monday, CBIO stock surged 234.21% to $1.27 with more than 235.31 million shares, compared to its average volume of 271K shares. The stock moved within…